Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE: 002020)
11.05
-0.11 (-0.99%)
Sep 9, 2024, 1:43 PM CST
Zhejiang Jingxin Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 4,139 | 3,920 | 3,717 | 3,401 | 3,214 | 3,604 | Upgrade
|
Other Revenue | 73.67 | 78.89 | 62.81 | 65.06 | 44.25 | 42.23 | Upgrade
|
Revenue | 4,212 | 3,999 | 3,780 | 3,467 | 3,258 | 3,647 | Upgrade
|
Revenue Growth (YoY) | 9.59% | 5.79% | 9.04% | 6.40% | -10.66% | 23.88% | Upgrade
|
Cost of Revenue | 2,072 | 1,988 | 1,774 | 1,547 | 1,277 | 1,282 | Upgrade
|
Gross Profit | 2,140 | 2,011 | 2,006 | 1,920 | 1,981 | 2,364 | Upgrade
|
Selling, General & Admin | 1,021 | 994.61 | 984.94 | 970.72 | 1,178 | 1,588 | Upgrade
|
Research & Development | 426.68 | 400.79 | 367.04 | 334.14 | 257.91 | 252.58 | Upgrade
|
Other Operating Expenses | 51.94 | 30.09 | 36.19 | 26.57 | 28.02 | 35.39 | Upgrade
|
Operating Expenses | 1,515 | 1,432 | 1,392 | 1,342 | 1,462 | 1,878 | Upgrade
|
Operating Income | 625.25 | 579.08 | 613.8 | 577.8 | 519.31 | 486 | Upgrade
|
Interest Expense | -8.92 | -7.31 | -6.01 | -4.97 | -6 | -10.61 | Upgrade
|
Interest & Investment Income | 71.77 | 66.71 | 85.05 | 96.29 | 79.73 | 88.75 | Upgrade
|
Currency Exchange Gain (Loss) | -1.07 | 3.43 | 14.43 | -3.84 | -9.77 | 1.75 | Upgrade
|
Other Non Operating Income (Expenses) | -1.35 | -0.97 | -3.21 | -7.19 | -9.77 | -1.73 | Upgrade
|
EBT Excluding Unusual Items | 685.68 | 640.94 | 704.06 | 658.09 | 573.49 | 564.16 | Upgrade
|
Impairment of Goodwill | - | - | - | - | - | -1.6 | Upgrade
|
Gain (Loss) on Sale of Investments | 24.16 | 24.44 | 10.15 | 7.23 | 131.49 | 1.59 | Upgrade
|
Gain (Loss) on Sale of Assets | 2.77 | 6.86 | 0.61 | -0.48 | -0.04 | -2.07 | Upgrade
|
Asset Writedown | -0.02 | -0.01 | -0.07 | -8.42 | -0.51 | -0.74 | Upgrade
|
Other Unusual Items | 110.58 | 35.81 | 35.56 | 43.12 | 54.54 | 42.08 | Upgrade
|
Pretax Income | 823.18 | 708.04 | 750.32 | 699.54 | 758.98 | 603.41 | Upgrade
|
Income Tax Expense | 112.34 | 84.62 | 82.49 | 81.57 | 105.65 | 81.47 | Upgrade
|
Earnings From Continuing Operations | 710.84 | 623.42 | 667.82 | 617.96 | 653.33 | 521.95 | Upgrade
|
Minority Interest in Earnings | -5.74 | -4.52 | -5.57 | -5.42 | -0.26 | -1.55 | Upgrade
|
Net Income | 705.1 | 618.9 | 662.25 | 612.54 | 653.07 | 520.4 | Upgrade
|
Net Income to Common | 705.1 | 618.9 | 662.25 | 612.54 | 653.07 | 520.4 | Upgrade
|
Net Income Growth | 3.52% | -6.55% | 8.12% | -6.21% | 25.49% | 40.92% | Upgrade
|
Shares Outstanding (Basic) | 860 | 860 | 860 | 817 | 796 | 855 | Upgrade
|
Shares Outstanding (Diluted) | 860 | 860 | 860 | 817 | 796 | 855 | Upgrade
|
Shares Change (YoY) | -0.25% | -0.06% | 5.31% | 2.55% | -6.90% | -1.28% | Upgrade
|
EPS (Basic) | 0.82 | 0.72 | 0.77 | 0.75 | 0.82 | 0.61 | Upgrade
|
EPS (Diluted) | 0.82 | 0.72 | 0.77 | 0.75 | 0.82 | 0.61 | Upgrade
|
EPS Growth | 3.78% | -6.49% | 2.67% | -8.54% | 34.80% | 42.86% | Upgrade
|
Free Cash Flow | 546.26 | 273.32 | 340.2 | -33.37 | 179.21 | 197.97 | Upgrade
|
Free Cash Flow Per Share | 0.63 | 0.32 | 0.40 | -0.04 | 0.23 | 0.23 | Upgrade
|
Dividend Per Share | 0.300 | 0.300 | 0.300 | 0.300 | 0.292 | 0.292 | Upgrade
|
Dividend Growth | 0% | 0% | 0% | 2.85% | 0% | 16.68% | Upgrade
|
Gross Margin | 50.81% | 50.30% | 53.06% | 55.39% | 60.80% | 64.84% | Upgrade
|
Operating Margin | 14.84% | 14.48% | 16.24% | 16.67% | 15.94% | 13.33% | Upgrade
|
Profit Margin | 16.74% | 15.48% | 17.52% | 17.67% | 20.04% | 14.27% | Upgrade
|
Free Cash Flow Margin | 12.97% | 6.84% | 9.00% | -0.96% | 5.50% | 5.43% | Upgrade
|
EBITDA | 865.36 | 778.68 | 766.56 | 713.89 | 642.51 | 592.21 | Upgrade
|
EBITDA Margin | 20.54% | 19.47% | 20.28% | 20.59% | 19.72% | 16.24% | Upgrade
|
D&A For EBITDA | 240.1 | 199.6 | 152.76 | 136.09 | 123.2 | 106.21 | Upgrade
|
EBIT | 625.25 | 579.08 | 613.8 | 577.8 | 519.31 | 486 | Upgrade
|
EBIT Margin | 14.84% | 14.48% | 16.24% | 16.67% | 15.94% | 13.33% | Upgrade
|
Effective Tax Rate | 13.65% | 11.95% | 10.99% | 11.66% | 13.92% | 13.50% | Upgrade
|
Revenue as Reported | 4,212 | 3,999 | 3,780 | 3,467 | 3,258 | 3,647 | Upgrade
|
Advertising Expenses | - | - | - | 5.13 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.